StockData

Cartesian Therapeutics, Inc. (RNAC) income statement

RNACNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 1/30
$6.14+0.25 (+4.24%)

Close on Nov 20, 2026Market cap $185.77MP/E –Yield –

Cartesian Therapeutics, Inc. financial ratios

See a number that looks wrong?